Arcatron Partners with OrbiMed for Growth

Arcatron Mobility Pvt. Ltd., a fast-growing consumer medical company, announced that it has raised growth capital from OrbiMed, a global healthcare-focused investment firm. Existing investors BL Taparia Family Office, Chona Family Office, MGA Ventures and founders of Arcatron also participated in the round. The funds will be utilized to ramp up R&D efforts, develop new products and enhance branding and marketing.

Frido’s Mobility Assist Devices

Arcatron under its flagship brand “Frido” offers mobility assist devices like wheelchairs for patients with limited mobility, orthopaedic insoles and ergonomic cushions for pain relief and comfort enhancement. The company offers its products across all leading e-commerce platforms, its own website and 1,000+ stores across the country.

Collaboration

• Arcatron's founders Ganesh Sonawane and Arif Khan, view this investment as a catalyst for expanding product development and reaching more customers. They are excited about the opportunities that this partnership with OrbiMed opens up.

• Dr. Sunny Sharma and Sumona Chakraborty of OrbiMed are joining the board of Arcatron. Dr. Sunny Sharma, partner and senior managing director OrbiMed Asia, said, “We are very impressed with the team’s expertise in product development and marketing, and are excited to partner with Arcatron in building a leading consumer medical company. 

About Arcatron Mobility

Arcatron Mobility is a consumer medical company offering mobility assist devices like wheelchairs for patients with limited mobility, orthopaedic insoles and ergonomic cushions for pain relief and comfort enhancement. Based in Pune, India, Arcatron is dedicated to making a positive impact by solving unmet needs for its customers.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!